ERS 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

ERS 2022

22 September, 2022 02:57

Physical activity improves asthma control

Presented By

Morten Hostrup, University of Copenhagen, Denmark

Conference

NLC 2022

17 August, 2022 16:30

Tailored exercise needed for COPD patients

Presented By

Prof. Andre Nyberg, Umea University, Sweden

Conference

NLC 2022

17 August, 2022 16:28

Asthma increases risks around delivery

Presented By

Dr Paula Kauppi, University of Helsinki, Finland

Conference

NLC 2022

17 August, 2022 16:13

PRO-ART study: unravelling the link between asthma and subfertility

Presented By

Dr Anne Hansen, Copenhagen University Hospital, Denmark

Trial

Phase 2, PRO-ART

Conference

NLC 2022

17 August, 2022 16:10

Early-onset and uncontrolled asthma: strong association with recurrent pregnancy loss

Presented By

Dr Casper Tidemandsen, Copenhagen University Hospital, Denmark

Conference

NLC 2022

17 August, 2022 16:08

Round-up of respiratory disease and reproduction topics

Conference

NLC 2022

17 August, 2022 16:06

Severe asthma in the spotlights

Presented By

Prof. Lena Uller, Lund University, Sweden

Conference

NLC 2022

17 August, 2022 15:58

Common comorbidities in severe asthma

Presented By

Dr Asger Sverrild, Bispebjerg Hospital, Denmark

Conference

NLC 2022

17 August, 2022 15:56

Switching biologicals in severe asthma

Conference

NLC 2022

17 August, 2022 15:53

Targeting treatable traits allows a personalised approach to management of (severe) asthma

Presented By

Dr Florence Schleich, University of Liège, Belgium

Conference

NLC 2022

17 August, 2022 15:44

Exercise-induced laryngeal obstruction (EILO) is often misdiagnosed

Presented By

Dr Emil Walsted, Bispebjerg Hospital, Denmark

Conference

NLC 2022

17 August, 2022 15:40

The ULANC Group: working together in CRSwNP/asthma

Presented By

Prof. Vibeke Backer, Rigshospitalet/Copenhagen University, Denmark

Conference

NLC 2022

17 August, 2022 15:29

E-cigarettes impose detrimental effects on health

Presented By

Dr Linnea Hedman, Umeå University, Sweden

Conference

NLC 2022

17 August, 2022 14:34

Effects of passive vaping in COPD patients

Presented By

Prof. Torben Sigsgaard, Aarhus University, Denmark

Conference

NLC 2022

17 August, 2022 14:32

NLC 2022 Highlights Podcast

Presented By

Dr Robert van den Heuvel, Medicom

Conference

NLC 2022

17 August, 2022 09:20

MANDALA and DENALI pattern success for albuterol-budesonide in asthma

Presented By

Prof. Alberto Papi, University of Ferrara, Italy & Dr Bradley Chipps, Capital Allergy & Respiratory Disease Center, CA, USA

Trial

Phase 3, MANDALA, DENALI

Conference

ATS 2022

18 July, 2022 13:05

ACOUSTICS data sounds good for adolescent asthma exacerbations

Presented By

Prof. Stanley Szefler, Children’s Hospital Colorado, CO, USA

Trial

Phase 3, ACOUSTICS

Conference

ATS 2022

18 July, 2022 13:02

Type 2 asthma in children managed by dupilumab, despite atopic comorbidities

Presented By

Prof. Theresa Guilbert, University of Cincinnati, OH, USA

Trial

Phase 3, Liberty Asthma VOYAGE

Conference

ATS 2022

18 July, 2022 13:00

NAVIGATOR steers asthma patients to tezepelumab

Presented By

Prof. Njira Lugogo, University of Michigan, MI, USA

Trial

Phase 3, NAVIGATOR

Conference

ATS 2022

18 July, 2022 12:57

High-intensity interval training slashes daily corticosteroids in asthma

Presented By

Dr Anders Pitzner-Fabricius, Rigshospitalet Copenhagen, Denmark

Conference

ATS 2022

18 July, 2022 12:55

Three’s a crowd for triple therapy in COPD

Presented By

Prof. Claus Vogelmeier, Philipps-University Marburg, Germany

Conference

ATS 2022

18 July, 2022 12:40

Higher 1-year COPD mortality after hospitalisation for White patients

Presented By

Dr Snigdha Jain, Yale School of Medicine, CT, USA

Conference

ATS 2022

18 July, 2022 12:39

Reducing dyspnoea in chronic lung disease through weight loss

Presented By

Dr Maria Benzo, Mayo Clinic Rochester, MN, USA

Conference

ATS 2022

18 July, 2022 12:37

CT-evident mucus plugs in COPD associated with death

Presented By

Dr Alejandro Diaz, Brigham and Women’s Hospital, MA, USA

Trial

COPDGene

Conference

ATS 2022

18 July, 2022 12:35

Home-based rehabilitation improves COPD: a randomised study

Presented By

Dr Roberto Benzo, Mayo Clinic Rochester, MN, USA

Conference

ATS 2022

18 July, 2022 12:33

No screening evidence for COPD

Presented By

Prof. Carol Mangione, University of California at Los Angeles, CA, USA

Conference

ATS 2022

18 July, 2022 11:44

Telemedicine has mixed influence on costs of asthma care

Journal

The Journal of Allergy and Clinical Immunology: In Practice

17 June, 2022 16:07

ATS 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ATS 2022

9 June, 2022 07:34

Obesity may hinder response to immunotherapy for allergies, asthma, mouse study suggests

Journal

Nature

6 April, 2022 23:57

Live attenuated nasal-spray flu vaccine safe in kids with asthma

Journal

Pediatrics

30 March, 2022 15:58

Simple screening tools could help identify COPD in low-, middle-income countries

Journal

JAMA

20 January, 2022 20:25

Secondhand vaping linked with respiratory symptoms in young adults

Journal

Thorax

17 January, 2022 21:45

Dupilumab cuts severe asthma exacerbations by 59% in children aged 6 to 11

Journal

The New England Journal of Medicine

12 December, 2021 23:00

Immune-mediated diseases tied to risk of cancer

Journal

JAMA Oncology

9 December, 2021 21:17

Understudied low-lung-function state tied to increased risk of respiratory problems and death

Journal

The Lancet Respiratory Medicine

11 November, 2021 16:44

Fear of COVID-19 related to dyspnoea in COPD patients

Conference

ERS 2021

9 November, 2021 10:29

Rhinovirus bronchiolitis increased risk of recurrent wheezing and asthma

Presented By

Dr Heidi Makrinioti, Imperial College London, UK

Conference

ERS 2021

9 November, 2021 10:28

Livestock farming affected the airway microbiome of COPD patients

Presented By

Mr Warner van Kersen, Utrecht University, the Netherlands

Conference

ERS 2021

9 November, 2021 10:27

Adherence to singing training similar to standard physical therapy in COPD patients

Conference

ERS 2021

9 November, 2021 10:27

COPD symptoms and lung function related to sleep quality

Conference

ERS 2021

9 November, 2021 10:26

Reduction of COPD severe acute exacerbations by candidate vaccine

Presented By

Prof. Stefan Andreas, Gastarzt Abteilung Pneumologie der Medizinischen Klinik II Gießen, Germany

Conference

ERS 2021

9 November, 2021 10:26

The effect of the pandemic on the discharge diagnosis of older COPD patients

Conference

ERS 2021

9 November, 2021 10:25

Lower influenza vaccination coverage in children with chronic conditions

Conference

ERS 2021

9 November, 2021 10:24

Biomarkers do not discriminate severe from severe uncontrolled asthma

Presented By

Dr Bo Ding, AstraZeneca, Sweden

Trial

NOVELTY

Conference

ERS 2021

9 November, 2021 10:21

Increased blood neutrophiles in patients with obesity and asthma

Presented By

Dr Helena Backman, Umea University, Sweden

Conference

ERS 2021

9 November, 2021 10:20

Dynamics of environmental pollution during and after COVID-19 lockdown

Trial

POLCOV

Conference

ERS 2021

9 November, 2021 10:20

Magnesium supplements improved lung function in asthma patients

Conference

ERS 2021

9 November, 2021 10:19

Blood inflammatory phenotypes associated with clinical symptoms of asthma

Presented By

Dr Tajidine Tsiavia, University of Paris-Saclay, France

Conference

ERS 2021

9 November, 2021 10:19

Paradoxical bronchospasm may go unrecognized in patients with COPD or asthma

Conference

CHEST 2021 Annual Meeting

21 October, 2021 16:23

ERS 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ERS 2021

23 September, 2021 12:51

Circadian system implicated in asthma worsening at night

Journal

Proceedings of the National Academy of Sciences of the United States of America

17 September, 2021 22:55

Hotter weather may fuel spike in COPD flare-ups

Conference

ERS International Congress 2021

7 September, 2021 16:24

Restoring pulmonary endothelial cells reverses emphysema in mice

Journal

Journal of Experimental Medicine

29 July, 2021 16:33

Vaping identified as risk factor for asthma

Presented By

Prof. Theresa To, The Hospital for Sick Children, ON, Canada

Conference

ATS 2021

5 July, 2021 13:56

Obesity: A risk factor for new-onset asthma and worse asthma control

Presented By

Prof. Fernando Holguin, University of Colorado Asthma Research and Education, CO, USA

Trial

Cohort study, CARDIA

Conference

ATS 2021

5 July, 2021 13:52

Metabolic dysfunction and lung disease: children are no small adults

Presented By

Prof. Erick Forno, University of Pittsburgh, PA, USA

Conference

ATS 2021

5 July, 2021 13:52

Possible aetiologies for COPD exacerbations – more evidence is needed

Presented By

Prof. Surya P. Bhatt, Birmingham School of Medicine, AL, USA

Conference

ATS 2021

5 July, 2021 13:50

Does COPD plus COVID-19 equal higher mortality?

Presented By

Dr Jacob Schwartz, Lenox Hill Hospital, NY, USA

Conference

ATS 2021

5 July, 2021 13:50

Biomarkers for acute exacerbations in COPD are required

Presented By

Prof. Don D. Sin, University of British Columbia, BC, Canada

Conference

ATS 2021

5 July, 2021 13:50

Severe exacerbations: A key driver of all-cause mortality in COPD patients

Presented By

Prof. Manoj J. Mammen, Jacobs School of Medicine and Biomedical Sciences, NY, USA

Trial

Phase 3, IMPACT

Conference

ATS 2021

5 July, 2021 13:50

Men and women with COPD differ in many ways

Presented By

Dr Franziska Trudzinski, University Hospital Centre Heidelberg, Germany

Trial

Cohort study, cosyconet

Conference

ATS 2021

5 July, 2021 13:50

Younger adults with COPD at higher health risk than previously thought

Presented By

Dr Alina J. Blazer, University of Toronto, ON, Canada

Conference

ATS 2021

5 July, 2021 13:50

“As-needed” inhaled corticosteroid therapy for mild asthma – what is the evidence?

Presented By

Prof. Kaharu Sumino, Prof. Anne Dixon

Trial

SYGMA 1 and 2, PRACTICAL, START

Conference

ATS 2021

5 July, 2021 13:48

IL-4/13 blocker successful in treatment of paediatric moderate-to-severe asthma

Presented By

Prof. Leonhard B. Bacharier, Vanderbilt University Medical Center, TN, USA

Trial

VOYAGE

Conference

ATS 2021

5 July, 2021 13:48

Benralizumab lives up to its phase 3 results in real-world findings

Presented By

Dr Donna Carstens, AstraZeneca, Wilmington, DE, USA

Conference

ATS 2021

5 July, 2021 13:48

Tezepelumab – good success rates in various types of severe asthma

Presented By

Prof. Michael E. Wechsler, National Jewish Health, Denver, CO, USA

Trial

Phase 3, NAVIGATOR

Conference

ATS 2021

5 July, 2021 13:48

Frequent snoring tied to increased asthma symptoms, health care use in kids

Journal

Journal of Allergy and Clinical Immunology: In Practice

16 June, 2021 19:48

HRT tied to increased risk of severe asthma exacerbation

Journal

Journal of Allergy and Clinical Immunology: In Practice

26 March, 2021 19:03

Dupilumab an option when other targeted agents fail in aspirin-exacerbated respiratory disease

Journal

Journal of Allergy and Clinical Immunology: In Practice

5 March, 2021 17:37

No drop in oxygen saturation when asthma patients wear masks

Conference

AAAAI Virtual Annual Meeting

3 March, 2021 17:07

Grandmother’s smoking tied to asthma risk, lung function in some men

Journal

Thorax

1 March, 2021 17:53

AstraZeneca-Amgen drug could widen treatment options for severe asthma

26 February, 2021 15:00

Bronchial thermoplasty benefits for uncontrolled asthma sustained at 10 years

Journal

Lancet Respiratory Medicine

19 February, 2021 17:56

Proton pump inhibitor use tied to childhood asthma

Journal

JAMA Pediatrics

8 February, 2021 23:02

Benralizumab improves health-related quality of life in severe eosinophilic asthma

Journal

Lancet Respiratory Medicine

15 January, 2021 16:14

Screen COPD patients with worsening lung function for pulmonary embolism?

Journal

JAMA

5 January, 2021 19:28

Disinfecting during pandemic puts asthmatics at risk

Journal

Journal of Allergy and Clinical Immunology

4 January, 2021 23:36

Asthma inhaler sensors improve pediatric asthma control

Journal

Pediatrics

24 December, 2020 22:28

Halting asthma medication for pregnancy tied to adverse perinatal outcomes

9 December, 2020 23:01

New asthma guidelines advise single maintenance and reliever therapy

Journal

JAMA

7 December, 2020 14:35

Children with exercise-induced respiratory symptoms may get conflicting diagnoses

Journal

Pediatric Pulmonology

24 November, 2020 21:19

Vitamin D supplement improves asthma control in adults with deficiency

Journal

Thorax

23 November, 2020 17:45

Anti-IL-5 biologics effective for up to two years in severe asthma, but residual disease remains

Journal

Journal of Allergy and Clinical Immunology in Practice

29 October, 2020 22:45

Smartphone-based cough detection helpful in predicting asthma deterioration

Presented By

Dr Frank Rassouli, Cantonal Hospital St. Gallen, Switzerland

Conference

ERS 2020

29 October, 2020 19:53

The role of chronic symptoms as early biomarkers of COPD development

Presented By

Dr James Allinson, Imperial College London, UK

Conference

ERS 2020

29 October, 2020 18:29

Urgent call for studies in COPD patients aged 40-60 years

Presented By

Prof. Wisia Wedzicha , Imperial College London, UK

Conference

ERS 2020

29 October, 2020 18:25

Nasal high-flow therapy: a novel treatment option for hypercapnic COPD patients

Presented By

Dr Jens Bräunlich, Kliniken Aurich-Emden-Norden, Germany

Conference

ERS 2020

29 October, 2020 18:10

Exacerbation history is a reliable predictor of future exacerbations

Presented By

Prof. Claus Vogelmeier, Philipps University of Marburg, Germany

Trial

Cohort study, AvoidEx

Conference

ERS 2020

29 October, 2020 18:07

Singing training effective as physical rehabilitation in COPD

Presented By

Prof. Uffe Bødtger, Nætved Hospital, Denmark

Conference

ERS 2020

29 October, 2020 18:02

Mild asthma: A fundamental change in management

Presented By

Prof. Roland Buhl, Johannes Gutenberg University of Mainz, Germany

Conference

ERS 2020

29 October, 2020 17:55

Dupilumab shows long-term efficacy in asthma patients

Presented By

Dr Michael Wechsler, Prof. Chris Brightling

Trial

LIBERTY ASTHMA TRAVERSE, LUSTER

Conference

ERS 2020

29 October, 2020 17:47

Severe asthma: Oral corticosteroids maintenance therapy associated with toxicity

Presented By

Prof. Njira Lugogo, University of Michigan, USA

Trial

CHRONICLE

Conference

ERS 2020

29 October, 2020 17:42

First-in-class tyrosine kinase inhibitor shows promise in severe asthma

Presented By

Prof. Pascal Chanez, Aix-Marseille Université, France

Conference

ERS 2020

29 October, 2020 17:39

Predicting individual effectiveness of biologics in severe asthma

Presented By

Prof. Celeste Porsbjerg, Bispebjerg-Frederiksberg University Hospital, Denmark

Conference

ERS 2020

29 October, 2020 17:34

Current prediction tools underestimate exacerbation risk of severe COPD patients

Presented By

Mr Spencer Keene, Maastricht University, the Netherlands

Trial

ECLIPSE

Conference

ERS 2020

29 October, 2020 16:57

IL-5 antagonist showed efficacy in chronic rhinosinusitis with nasal polyps

Presented By

Dr Claire Hopkins, Guy’s and St Thomas Hospital and King’s College London, UK

Trial

Phase 3, SYNAPSE

Conference

ERS 2020

29 October, 2020 16:42

Treatment according to genotype: The future of asthma therapy?

Presented By

Dr Tom Ruffles, Brighton & Sussex Medical School, UK

Conference

ERS 2020

29 October, 2020 15:49

Oral cannabinoid drugs may worsen COPD outcomes

Journal

Thorax

27 October, 2020 16:21

Asthma rescue with budesonide-formoterol cuts short-term flare risk

Journal

Lancet Respiratory Medicine

9 October, 2020 17:19

Therapies for atopic dermatitis: still moving forward

Presented By

Prof. Christian Vestergaard, Aarhus University Hospital, Denmark

Conference

SPIN 2022

26 August, 2022 10:58

Children with AD: high risk of bacterial infections in carriers of a filaggrin gene variant

Presented By

Prof. Alina Suru , Carol Davila University of Medicine and Pharmacy, Romania

Conference

SPIN 2022

26 August, 2022 10:53

No adverse pregnancy outcomes in patients exposed to baricitinib

Conference

SPIN 2022

26 August, 2022 10:47

AD treatment during the pandemic: dupilumab does not raise COVID-19 infection risk

Presented By

Dr Brian Rankin, University of Calgary, Canada

Trial

Cohort study

Conference

AAD 2022

18 May, 2022 12:27

Upadacitinib: Fast and more pronounced skin improvement in AD patients

Presented By

Prof. Jonathan Silverberg, George Washington University School of Medicine, USA

Trial

Phase 3, Heads Up

Conference

AAD 2022

17 May, 2022 12:35

JAK inhibitors in AD: Setting the efficacy bar even higher

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Trial

Measure Up 1; JADE Mono-1; JADE Compare; Heads Up

Conference

AAD 2022

17 May, 2022 12:21

Novel IL-4/IL-13 blocker shows high efficacy with only modest conjunctivitis signal

Presented By

Prof. Andrew Blauvelt, Oregon Medical Research Center, USA

Conference

AAD 2022

17 May, 2022 12:15

JAK inhibitors: A risk assessment

Presented By

Prof. Brett King, Yale School of Medicine, USA

Conference

AAD 2022

17 May, 2022 10:59

Monitoring is key during JAK inhibitor therapy

Presented By

Prof. Jonathan Silverberg

Conference

AAD 2022

17 May, 2022 10:47

AAD 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

AAD 2022

14 April, 2022 11:02

FDA approves expanded use of AbbVie’s arthritis drug to treat eczema

14 January, 2022 21:36

Dupilumab for atopic dermatitis linked with milder COVID-19 symptoms

Journal

The Journal of Allergy and Clinical Immunology: In Practice

25 November, 2021 16:58

Targeting OX40 in the treatment of atopic dermatitis meets expectations

Presented By

Prof. Stephan Weidinger, University Hospital Schleswig-Holstein, Germany

Trial

Phase 2

Conference

EADV 2021

18 November, 2021 13:35

Superior EASI scores after switch from dupilumab to upadacitinib

Presented By

Prof. Andrew Blauvelt, Oregon Medical Research Center, USA

Trial

Heads Up

Conference

EADV 2021

18 November, 2021 13:34

Long-term disease control in AD could be in reach with anti-OX40 antibody KHK4083

Presented By

Prof. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, USA

Trial

Phase 2

Conference

EADV 2021

18 November, 2021 13:28

Abrocitinib demonstrates fast itch control and skin clearance in atopic dermatitis

Presented By

Prof. Kristian Reich, University Medical Center Hamburg-Eppendorf, Germany

Trial

Phase 3, JADE DARE

Conference

EADV 2021

18 November, 2021 13:26

AD patients with stable response fare well with a monthly dose of tralokinumab

Presented By

Prof. Stephan Weidinger, University of Kiel, Germany

Trial

ECZTRA1 and 2

Conference

EADV 2021

18 November, 2021 13:25

Upadacitinib beats dupilumab in different body regions

Presented By

Prof. Jacob Thyssen, Bispebjerg Hospital, Denmark

Trial

Phase 3, Heads Up

Conference

EADV 2021

18 November, 2021 13:23

Efficacious 2-year AD control with IL-13 inhibitor tralokinumab

Presented By

Prof. Andrew Blauvelt, Oregon Medical Research Center, USA

Trial

ECZTEND

Conference

EADV 2021

18 November, 2021 13:22

Ruxolitinib cream: a safe treatment for elderly AD patients

Presented By

Prof. Jacek Szepietowksi, Wroclaw Medical University, Poland

Trial

Phase 3, TRuE-AD1; TRuE-AD2

Conference

EADV 2021

18 November, 2021 13:21

Novel and upcoming targeted AD treatment

Presented By

Prof. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, USA

Trial

ECZTRA 3; Measure Up; ADVISE

Conference

EADV 2021

18 November, 2021 13:20

Opioid receptor agonist difelikefalin disappoints in AD

Presented By

Prof. Brian Kim, Washington University School of Medicine, USA

Trial

Phase 2, KARE

Conference

EADV 2021

17 November, 2021 14:28

Targeting oncostatin M curbs chronic itch in mice

Journal

Science Translational Medicine

16 November, 2021 22:22

EADV 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Trial

PSOARING 3, JADE-DARE, HEADS UP

Conference

EADV 2021

19 October, 2021 00:08

Potential first-in-class drug shows disease-modifying impact in atopic dermatitis

Conference

European Academy of Dermatology and Venereology 30th Virtual Congress

8 October, 2021 22:39

Do oral corticosteroids drive fracture risk in atopic eczema?

Journal

Journal of Allergy and Clinical Immunology: In Practice

1 October, 2021 21:52

Severe atopic dermatitis tied to depressive symptoms, internalizing behaviors in children

Journal

JAMA Dermatology

7 September, 2021 20:50

Pfizer study shows skin disease drug more effective than Regeneron rival

30 August, 2021 20:09

Oral abrocitinib plus topical therapy safe, effective for teens with moderate-to-severe atopic dermatitis

Journal

JAMA Dermatology

24 August, 2021 23:13

Upadacitinib bests dupilumab for adults with moderate-severe atopic dermatitis

Journal

JAMA Dermatology

10 August, 2021 22:22

Autologous bacteriotherapy shows promise against atopic dermatitis

Journal

JAMA Dermatology

24 June, 2021 17:39

Comorbidity does not influence crisaborole efficacy in atopic dermatitis

Trial

Phase 3, CrisADe CORE 1 and 2

Conference

AAD VMX 2021

7 June, 2021 13:30

Comorbidity is common in adult and paediatric atopic dermatitis patients

Presented By

Prof. Jonathan Silverberg, George Washington University, WA, USA

Conference

AAD VMX 2021

7 June, 2021 13:30

Significant improvements in the system armamentarium for AD treatment

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Conference

AAD VMX 2021

7 June, 2021 13:20

No increased risk of infection with long-term dupilumab for atopic dermatitis

Trial

LIBERTY AD OLE

Conference

AAD VMX 2021

7 June, 2021 13:15

Topical pan-JAK inhibitor cream safe and efficacious in atopic dermatitis

Presented By

Prof. Jonathan Silverberg, George Washington University, WA, USA

Conference

AAD VMX 2021

7 June, 2021 13:10

Atopic dermatitis in children has a severe impact on their families

Conference

AAD VMX 2021

7 June, 2021 13:05

Meaningful amelioration of quality of life in paediatric AD patients on dupilumab

Trial

Phase 3, LIBERTY AD PEDS

Conference

AAD VMX 2021

7 June, 2021 13:00

Etrasimod – a new mode of action for treatment of atopic dermatitis

Presented By

Prof. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, USA

Conference

AAD VMX 2021

7 June, 2021 10:45

Baricitinib shows long-term effectiveness against moderate to severe atopic dermatitis

Journal

JAMA Dermatology

4 June, 2021 16:35

Internet-delivered CBT improves atopic dermatitis symptoms

Journal

JAMA Dermatology

27 May, 2021 21:53

Oral JAK1 inhibitor shows promise for treating moderate to severe atopic dermatitis

Journal

The Lancet

21 May, 2021 22:53

Wildfire air pollution linked to jump in atopic dermatitis and itch dermatology visits

Journal

JAMA Dermatology

21 April, 2021 23:37

Atopic dermatitis linked to learning disability, educational achievement

Journal

JAMA Dermatology

20 April, 2021 00:07

Topical calcineurin inhibitors pose very little cancer risk

Journal

JAMA Dermatology

8 April, 2021 17:36

U.S. FDA extends review of Pfizer’s experimental skin disease drug

7 April, 2021 17:11

Pfizer’s atopic dermatitis drug bests dupilumab, but only at higher dose

Journal

The New England Journal of Medicine

24 March, 2021 23:40

Pediatric atopic dermatitis tied to school, work absenteeism

Journal

Journal of the American Academy of Dermatology

10 March, 2021 23:09

Severe atopic eczema tied to higher risk of premature death

Journal

Journal of Allergy and Clinical Immunology

28 January, 2021 16:09

Meaningful sleep improvement with IL-13 inhibition

Presented By

Prof. Jonathan Silverberg, George Washington University, USA

Trial

Phase 3, ECZTRA

Conference

EADV 2020

17 December, 2020 14:33

Baricitinib in AD: Efficacy paired with consistent long-term results

Presented By

Prof. Jonathan Silverberg , George Washington University, USA

Trial

Phase 3, BREEZE-AD3

Conference

EADV 2020

17 December, 2020 14:31

Topical JAK inhibition: a novel treatment option for patients with mild-to-moderate AD

Presented By

Prof. Megan Landis, University of Louisville School of Medicine, USA

Trial

Phase 2

Conference

EADV 2020

17 December, 2020 14:22

Oral JAK 1 inhibitor leads to fast itch relieve and remarkable skin clearance in AD

Presented By

Prof. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, USA

Trial

Phase 3, Measure Up

Conference

EADV 2020

17 December, 2020 13:24

Effects IL-13 blocker improves with longer treatment duration

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Trial

Phase 3, ECZTRA

Conference

EADV 2020

17 December, 2020 12:37

Baricitinib plus corticosteroids effectively treats atopic dermatitis

Journal

JAMA Dermatology

9 October, 2020 23:27

Baricitinib beneficial in head and neck AD

Presented By

Dr Eric Simpson, Oregon Health and Science University, USA

Trial

Phase 3, BREEZE-AD1 and BREEZE-AD2

Conference

AAD 2020

19 August, 2020 07:23

Good response and pruritus reduction in AD with novel selective JAK1 inhibitor

Presented By

Dr Melinda Gooderham

Trial

JADE MONO-2

Conference

AAD 2020

6 August, 2020 07:08

IL-13 blocker tralokinumab effective in AD

Presented By

Prof. Eric Simpson

Trial

ECZTRA

Conference

AAD 2020

6 August, 2020 07:06

Tape stripping – a painless way to distinguish AD and psoriasis?

Presented By

Dr Robert Bissonnette, Innovaderm Research, Canada

Conference

AAD 2020

6 August, 2020 07:05

IL-4/IL-13 blocker dupilumab effective in children with severe AD

Presented By

Prof. Amy S. Paller, Northwestern University Feinberg School of Medicine, USA

Trial

Phase 3, LIBERTY AD PEDS

Conference

AAD 2020

6 August, 2020 07:04

Better compliance in AD skin care with novel emollient stick

Conference

AAD 2020

6 August, 2020 06:37

Small molecules: interesting novel treatment options in AD

Presented By

Prof. Tilo Biedermann, Helmholtz Center Munich, German

Conference

EADV 2019

9 December, 2019 20:27

IL-1⍺ blockade: a new treatment option in AD

Presented By

Prof. Alice Gottlieb, Icahn School of Medicine at Mount Sinai, USA

Conference

EADV 2019

9 December, 2019 19:51

IL-4/IL-13 blockade leads to rapid itch reduction in adolescents

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Trial

Phase 3, LIBERTY AD ADOL

Conference

EADV 2019

9 December, 2019 18:58

JAK inhibition plus TCS lead to high clearance rates in AD

Presented By

Prof. Kristian Reich, Georg-August-University Göttingen, Germany

Trial

Phase 3, BREEZE-AD7

9 December, 2019 16:53

How to manage conjunctivitis in AD patients treated with a biologic

Presented By

Prof. Tilo Biedermann, Helmholtz Center Munich, Germany

Conference

EADV 2019

9 December, 2019 16:01

Biologics: increasingly used in paediatric dermatology

Presented By

Prof. Marieke Seyger, Radboud University Nijmegen, the Netherlands

Conference

EADV 2019

9 December, 2019 15:16

No cancer risk with long-term use of tacrolimus, a topical calcineurin inhibitor, in children with AD

Presented By

Prof. Regina Fölster-Holst, University Medical Center Schleswig-Holstein, Germany

Trial

APPLES

Conference

EADV 2019

9 December, 2019 15:04

Green light for a second JAK inhibitor in AD

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Trial

Phase 3, JADE MONO-1

Conference

EADV 2019

9 December, 2019 14:06

Comorbidities more common in chronic urticaria, psoriasis, and AD

Presented By

Dr Karsten Weller, Charité University Hospital, Germany

Conference

EADV 2019

9 October, 2019 20:40

Reduced sleep quality in dermatoses influenced by itch and pain

Presented By

Dr Karolina Kaaz, Wroclaw Medical University, Poland

Conference

EADV 2019

9 October, 2019 19:58

Anxiety and depression are common in families of AD infants

Presented By

Dr Vesna Grivcheva-Panovska, University Clinic in Skopje (Macedonia)

Conference

EADV 2019

9 October, 2019 18:59

Statin use elevates risk of eczema and atopic dermatitis

Conference

WCD 2019

26 August, 2019 20:50

Cutaneous adverse events due to EGFR inhibitors

Presented By

Dr Pietro Sollena, University of the Sacred Heart in Rome, Italy

Conference

WCD 2019

26 August, 2019 20:44

Insights into pathogenesis of AD define novel therapeutic targets

Presented By

Prof. Graham Ogg & Prof. Emma Guttman-Yassky

Conference

WCD 2019

26 August, 2019 20:29

Long awaited oral therapy for moderate-to-severe AD

Presented By

Prof. Thomas Bieber, University Medical Center Bonn, Germany

Conference

WCD 2019

26 August, 2019 19:14

Reduction in coronary artery disease in psoriasis patients treated with biologic therapies, possible implications for atopic dermatitis

Presented By

Dr Nehal Mehta; Prof. Emma Guttman-Yassky

Trial

NHANES

Conference

SPIN 2019

21 June, 2019 14:38

Atopic dermatitis and psoriasis: on a spectrum?

Presented By

Prof. Emma Guttman-Yassky, Mount Sinai Medical School, USA

Conference

SPIN 2019

21 June, 2019 13:39

Bermekimab – a future treatment for atopic dermatitis?

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Conference

AAD 2019

19 April, 2019 22:17

New and emerging atopic dermatitis therapies

Presented By

Prof. David Cohen, New York University School of Medicine, USA

Conference

AAD 2019

19 April, 2019 20:43

Tralokinumab improves eczema and reduces staphylococcus aureus colonisation in AD

Conference

AAD 2019

19 April, 2019 18:14

Can JAK inhibitors close the current therapeutic gap in AD?

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Conference

AAD 2019

19 April, 2019 14:12

Living in the golden age of psoriasis and atopic dermatitis therapies

Expert

Dr Erik Joseph Stratman, Marshfield Clinic, Wisconsin, USA

Conference

AAD 2018

21 December, 2018 16:46

PACIFIC-AF: Low bleeding rates for asundexian in atrial fibrillation

Presented By

Prof. Manesh Patel, Duke University School of Medicine, USA

Trial

Phase 2, PACIFIC-AF

Conference

ACC 2022

15 June, 2022 13:31

Sex differences revealed in AF determinants and AF progression

Presented By

Prof. Michiel Rienstra, University Medical Center Groningen, Netherlands

Trial

RACE V

Conference

EHRA 2022

1 June, 2022 10:50

Early rhythm-control therapy efficacious in men and women with AF

Presented By

Prof. Isabelle van Gelder, University Medical Center Groningen, Netherlands

Trial

EAST-AFNET 4

Conference

EHRA 2022

1 June, 2022 10:47

Progression in remote app-based monitoring of atrial fibrillation

Presented By

Prof. Dominik Linz, Maastricht University Medical Center, the Netherlands

Trial

Telecheck-AF

Conference

EHRA 2022

1 June, 2022 10:41

First results of the POWER FAST III trial

Presented By

Prof. José Luis Merino, La Paz University Hospital, Spain

Trial

POWER FAST III

Conference

EHRA 2022

1 June, 2022 10:35

Real-world safety results on pulsed-field ablation with pentaspline catheter

Presented By

Dr Vivek Reddy, Mount Sinai Hospital, NY, USA

Trial

MANIFEST-PF

Conference

EHRA 2022

1 June, 2022 10:30

Low AF recurrence rates after PVI using pulsed-field ablation

Presented By

Mr Thomas Kueffer, University of Bern, Switzerland

Conference

EHRA 2022

1 June, 2022 10:19

Ultrasound-guided femoral venipuncture reduces complications in catheter ablation

Presented By

Dr Jana Haskova, Institute for Clinical and Experimental Medicine, Czechia

Conference

EHRA 2022

1 June, 2022 10:10

Focus on the efficacy of cardiac resynchronisation therapy in HF plus concomitant AF

Presented By

Dr Frederik Dalgaard, Herlev and Gentofte Hospital, Denmark

Conference

EHRA 2022

1 June, 2022 09:52

Insertable cardiac monitors effective for AF detection in cryptogenic stroke

Presented By

Dr Barbara Ratajczak-Tretel, University of Oslo, Norway

Trial

NOR-FIB

Conference

EHRA 2022

1 June, 2022 09:30

Developments in imaging tools for AF

Presented By

Prof. Lluis Mont , University of Barcelona, Spain

Conference

EHRA 2022

31 May, 2022 22:17

Large impact of remote screening tool on sleep apnoea diagnoses in AF

Presented By

Dr Dominique Verhaert, Maastricht University Medical Center, Netherlands

Conference

EHRA 2022

31 May, 2022 22:08

Impact of AF screening on stroke prevention influenced by systolic blood pressure

Presented By

Dr Lucas Yixi Xing, Copenhagen University Hospital, Denmark

Conference

EHRA 2022

31 May, 2022 21:53

Genetic testing for early-onset AF yields important prognostic information

12 May, 2022 15:32

DOACs safe, effective for A-fib patients with newly diagnosed cancer

Conference

ACC 2022

11 May, 2022 19:38

Inhaled flecainide promising for atrial fibrillation

Journal

Circulation: Arrhythmia and Electrophysiology

24 March, 2022 19:06

NOAC could be better than warfarin in diabetes patients with atrial fibrillation

Journal

Annals of Internal Medicine

15 February, 2022 17:54

Apixaban plus P2Y12 inhibitor likely best for AF after ACS or PCI

Journal

Journal of the American College of Cardiology

31 January, 2022 23:26

Jury still out on value of screening for atrial fibrillation

Journal

JAMA

25 January, 2022 17:44

New developments in remote diagnostics and monitoring of AF

Presented By

Dr Steven Lubitz, Massachusetts General Hospital, USA

Conference

AHA 2021

14 January, 2022 13:23

Head-to-head: Efficacy of dabigatran versus warfarin on cognitive impairment

Presented By

Prof. Bruno Caramelli, University of São Paulo, Brazil

Trial

Phase 4, GIRAF

Conference

AHA 2021

14 January, 2022 13:11

Posterior left pericardiotomy safe and effective in reducing atrial fibrillation

Presented By

Dr Mario Gaudino, Weill Cornell Medical Center, USA

Trial

PALACS

Conference

AHA 2021

14 January, 2022 13:05

LAA ligation did not reduce recurrent atrial arrhythmias in persistent AF

Presented By

Dr David Wilber, Loyola University Chicago, USA

Trial

aMAZE

Conference

AHA 2021

14 January, 2022 12:59

Equal benefits of early rhythm control in AF subtypes

Presented By

Dr Andreas Goette, St. Vincenz Hospital Paderborn, Germany

Trial

EAST-AFNET 4

Conference

AHA 2021

14 January, 2022 12:52

Younger patients benefit most from catheter ablation for AF, but the elderly do, too

Journal

Circulation

10 January, 2022 17:34

Blood thinner drug Xarelto tied to higher rate of major side effects – study

Journal

JAMA

21 December, 2021 22:07

AHA 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

AHA 2021

30 November, 2021 23:20

Atrial fibrillation symptoms less likely to be noticed by patients with diabetes

Journal

Journal of the American Heart Association

18 November, 2021 17:14

Women with breast cancer at increased risk for developing atrial fibrillation

Journal

European Heart Journal

18 November, 2021 16:25

Simple surgical maneuver tied to reduction in a-fib risk after cardiac surgery

Journal

The Lancet

17 November, 2021 22:06

Fitbit algorithm reliably detects atrial fibrillation

Conference

American Heart Association (AHA) Scientific Sessions 2021

17 November, 2021 15:32

Early cardioversion tied to lower risk of mortality in newly diagnosed AF

Journal

The BMJ

12 November, 2021 17:42

AI-enabled ECG algorithm predicts atrial fibrillation risk in migraine

Presented By

Dr Nikita Chhabra, Mayo Clinic, NY, USA

Conference

IHC 2021

8 November, 2021 14:45

Stroke risk rises transiently with AF episodes in patients with implanted cardiac devices

Journal

JAMA Cardiology

4 October, 2021 23:58

IHC 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

IHC 2021

30 September, 2021 23:06

Healthy sleep patterns tied to healthier heart rhythms

Journal

Journal of the American College of Cardiology

22 September, 2021 16:35

Continuous monitoring detects atrial fibrillation up to 30 days after discharge

Journal

JAMA Network Open

21 September, 2021 23:28

Genetic testing in early AF may reveal more serious congenital problems

Journal

JAMA Cardiology

17 September, 2021 22:56

ESC 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Trial

EMPEROR-Preserved, ENVISAGE-TAVI, TOMAHAWK, FIGARO-DKD, FIDELITY, STEP, GUIDE-HF

Conference

ESC 2021

14 September, 2021 20:32

No support for continuous AF screening with implantable loop recorder

Journal

The Lancet

1 September, 2021 17:36

Drinking alcohol tied to increased atrial fibrillation risk hours later

Journal

Annals of Internal Medicine

31 August, 2021 23:33

Omecamtiv mecarbil might be less effective in patients with atrial fibrillation or flutter

Presented By

Prof. Scott Solomon, Brigham and Women’s Hospital, MA, USA

Trial

GALACTIC-HF

Conference

HFA 2021

19 August, 2021 15:52

Vericiguat effective irrespective of atrial fibrillation status

Presented By

Prof. Piotr Ponikowski, Wrocław Medical University, Poland

Trial

VICTORIA

Conference

HFA 2021

19 August, 2021 15:45

COVID-19 in AF patients with HF: no higher mortality but longer hospital stay

Presented By

Prof. Bektaş Murat, Eskisehir Osmangazi University, Turkey

Conference

HFA 2021

19 August, 2021 09:38

Psychoactive substances put young people at risk of cardiovascular disease

Presented By

Dr Vijay Chopra, Max Super Speciality Hospital Saket, India

Conference

HFA 2021

19 August, 2021 09:28

Can a glass of wine a day keep a-fib away?

Journal

Journal of the American College of Cardiology (JACC): Clinical Electrophysiology

29 July, 2021 18:19

Atrial fibrillation after SAVR or TAVR tied to poorer outcome

Journal

JACC: Cardiovascular Interventions

27 July, 2021 15:51

Apixaban has benefits over other DOACs in frail adults with atrial fibrillation

Journal

Annals of Internal Medicine

20 July, 2021 16:16

Athletes may have doubled A-fib risk compared to general public

Journal

British Journal of Sports Medicine

13 July, 2021 00:30

Favourable outcomes with transcatheter atrial appendage occlusion

Presented By

Dr Matthew Price, Scripps Clinic, USA

Trial

PROTECT AF, PREVAIL

Conference

ACC 2021

9 July, 2021 23:31

STRENGTH trial fails to demonstrate cardioprotective effect of omega-3 fatty acids

Presented By

Dr Steven Nissen, Cleveland Clinic, USA

Trial

STRENGTH, REDUCE-IT

Conference

ACC 2021

9 July, 2021 23:25

Ablation-based rhythm control as effective as rate control in AF and HF

Presented By

Prof. Anthony Tang, University of Ottawa, Canada

Trial

RAFT-AF

Conference

ACC 2021

9 July, 2021 14:41

Finerenone reduces the risk of AF onset in patients with CKD and diabetes

Presented By

Prof. Gerasimos Filippatos, Attikon University Hospital, Greece

Trial

Phase 3, FIDELIO-DKD

Conference

ACC 2021

9 July, 2021 13:46

With hypertrophic cardiomyopathy, age and BMI among predictors of AFib events

Journal

JACC: Clinical Electrophysiology

8 July, 2021 22:43

Ablation bests drug therapy for minorities with afib in North America

Journal

Journal of the American College of Cardiology

7 July, 2021 15:10

No benefit to post-op heparin bridging in patients who stop warfarin for a procedure

Journal

The BMJ

17 June, 2021 16:41

ECG biomarker identifies AFib patients most likely to benefit from electrical stimulation

Journal

Journal of the American Heart Association

17 June, 2021 16:38

EHRA Practical Guide on cardiac imaging in electrophysiology

Presented By

Prof. Thomas Deneke, Heart Centre Bad Neustadt, Germany

Conference

EHRA 2021

16 June, 2021 14:37

Early rhythm-control ablation: insight from the CHARISMA registry

Presented By

Dr Luca Segreti, Azienda Ospedaliero, Universitaria Pisana, Italy

Trial

CHARISMA

Conference

EHRA 2021

16 June, 2021 14:17

Personalised pulmonary vein isolation procedure feasible and effective

Presented By

Dr Cheryl Terés, Teknon Medical Centre, Spain

Trial

Ablate-by-LAW

Conference

EHRA 2021

16 June, 2021 14:11

Pulmonary vein isolation: cryoballoon non-inferior to radiofrequency ablation

Presented By

Dr Bastian Kaiser, Robert-Bosch-Hospital Bad Cannstatt, Germany

Conference

EHRA 2021

16 June, 2021 13:21

Pulmonary vein isolation lesions plus personalised methods shows promising results

Conference

EHRA 2021

16 June, 2021 13:18

Predictors of young-onset atrial fibrillation

Presented By

Dr Amitai Segev, Sheba Medical Centre, Israel

Conference

EHRA 2021

16 June, 2021 13:11

RACE 3 long-term results show fading benefit of targeted therapies in AF and HF

Presented By

Prof. Michiel Rienstra, University Medical Center Groningen, the Netherlands

Trial

RACE 3

Conference

EHRA 2021

16 June, 2021 13:07

Deep dive into EAST-AFNET 4 results on early rhythm-control in atrial fibrillation

Presented By

Dr Andreas Metzner, University Heart & Vascular Centre Hamburg, Germany

Trial

EAST-AFNET 4

Conference

EHA 2021

16 June, 2021 13:00

Cryo-FIRST study: improved AF and QoL outcomes with cryoballoon versus drug therapy

Presented By

Dr Nikola Pavlović, University Hospital Sestre Milosrdnice, Croatia

Trial

Phase 4, Cryo-FIRST

Conference

EHRA 2021

16 June, 2021 12:43

STROKESTOP: Benefits of systematic screening for atrial fibrillation

Presented By

Dr Emma Svennberg, Karolinska Institute, Denderyd Hospital, Sweden

Trial

STROKESTOP

Conference

EHRA 2021

16 June, 2021 12:38

DOACs and bleeding: the role of antidotes

Presented By

Dr Kaveshree Govender, Milpark Hospital, South Africa

Trial

RE-VERSE AD

Conference

EHRA 2021

16 June, 2021 10:26

2021 EHRA practical guide: DOACs in pre-operative and bleeding patients

Presented By

Prof. Thomas Vanassche, University Hospitals Leuven, Belgium

Conference

EHRA 2021

15 June, 2021 15:37

Accelerometer-derived physical activity tied to atrial fibrillation risk

Journal

European Heart Journal

2 June, 2021 23:13

Wearables tied to more health care use with atrial fibrillation

Journal

JAMA Network Open

1 June, 2021 23:09

Continuous cardiac monitoring detects substantial rates of subclinical AF after stroke

Journal

JAMA

1 June, 2021 17:26

In healthy afib patients ages 65-74, anticoagulation likely benefits only those who are older

Journal

JAMA Cardiology

28 May, 2021 22:18

Early rhythm control may best rate control in recently diagnosed AF

Journal

BMJ

24 May, 2021 22:29

Finerenone may delay onset of atrial fibrillation in at-risk patients

Journal

Journal of the American College of Cardiology

21 May, 2021 16:12

Afib patients benefit when left-atrial-appendage occlusion added to their heart surgery

Journal

The New England Journal of Medicine

17 May, 2021 17:01

Anticoagulation common near end of life in dementia patients with AFib

Journal

JAMA Internal Medicine

10 May, 2021 18:10

Pulsed field ablation effective against paroxysmal atrial fibrillation

Journal

JACC: Clinical Electrophysiology

10 May, 2021 15:49

Catheter ablation likely more effective than drugs for paroxysmal atrial fibrillation

Journal

JAMA Cardiology

4 May, 2021 22:35

Many patients on DOACs receive concurrent non-indicated aspirin tied to bleeding risk

Journal

JAMA Internal Medicine

22 April, 2021 21:43

DOACs safer, more effective than warfarin in valvular atrial fibrillation

Journal

Annals of Internal Medicine

29 March, 2021 23:00

Screening with wearable ECG increased AF detection 10-fold in hypertensive older adults

Journal

JAMA Cardiology

2 March, 2021 04:37

Disparities in rhythm control treatment for atrial fibrillation

Journal

JAMA Network Open

26 February, 2021 22:03

AF monitoring following cardiovascular surgery

Presented By

Prof. Subodh Verma, University of Toronto, Canada)

Trial

SEARCH-AF

Conference

AHA 2020

18 February, 2021 10:54

Pre-diabetes tied to increased stroke risk with nonvalvular atrial fibrillation

Journal

Journal of the American College of Cardiology

17 February, 2021 23:54

Vitamin D or omega 3 fatty acids do not prevent AF

Presented By

Prof. Christine Albert, Cedars-Sinai Medical Center, USA

Trial

VITAL Rhythm

Conference

AHA 2020

17 February, 2021 14:19

Active screening for AF improves clinical outcomes

Presented By

Dr Steven Steinhubl, Scripps Research Translational Institute, USA

Trial

mSToPS

Conference

AHA 2020

17 February, 2021 14:16

AF screening in older adults at primary care visits

Presented By

Dr Steven Lubitz, Massachusetts General Hospital, USA

Trial

VITAL-AF

Conference

AHA 2020

17 February, 2021 14:06

Unfavourable outcomes for COVID-19 patients with AF and atrial flutter

Presented By

Dr Zaniar Ghazizadeh, Brigham and Women’s Hospital, USA

Trial

Yale Cardiovascular COVID Registry

Conference

AHA 2020

17 February, 2021 12:08

High blood pressure likely to be causally linked to atrial fibrillation

Journal

European Journal of Preventive Cardiology

11 February, 2021 17:20

Just one drink a day can raise risk of developing atrial fibrillation

Journal

European Heart Journal

13 January, 2021 23:07

Left atrial appendage occlusion tied to less afib bleeding, mortality vs DOACs

Journal

JACC: Cardiovascular Interventions

12 January, 2021 23:20

Cryoablation Afib studies show better first-line outcomes than drug therapy

Journal

New England Journal of Medicine

Conference

AHA 2020

16 November, 2020 21:05

Rivaroxaban not inferior to warfarin for afib patients with artificial mitral valve

Journal

New England Journal of Medicine

Conference

AHA 2020

16 November, 2020 20:20

Direct oral anticoagulants may best vitamin K agonists for post-TAVR a-fib

Journal

JACC: Cardiovascular Interventions

12 November, 2020 16:28

Cryoballoon supplement to pulmonary-vein isolation curbs AF recurrence

Journal

JACC: Clinical Electrophysiology

6 November, 2020 21:14

2020 Atrial Fibrillation Guidelines

Presented By

Prof. Gerhard Hindricks, Heart Centre Leipzig, Germany

Conference

ESC 2020

5 November, 2020 14:05

Reduced cardiovascular outcomes with early rhythm control

Presented By

Prof. Paulus Kirchhof, University Heart & Vascular Center Hamburg, Germany

Trial

EAST-AFNET 4

Conference

ESC 2020

5 November, 2020 13:35

Drug initiation strategy not associated with increased use of oral anticoagulants

Presented By

Prof. Sean Pokorney , Duke University, USA

Trial

IMPACT-AFib trial

Conference

ESC 2020

5 November, 2020 13:07

Digoxin improves symptoms in stable patients with permanent AF

Presented By

Prof. Dipak Kotecha, University of Birmingham, UK

Trial

Phase 4, RATE-AF trial

Conference

ERS 2020

5 November, 2020 12:45

Bacterial decolonisation effective against radiation dermatitis

Presented By

Ms Yana Kost, Albert Einstein College of Medicine, NY, USA

Conference

ASCO 2022

5 August, 2022 15:38

Sacituzumab govitecan meets primary endpoint 

Presented By

Prof. Hope Rugo, University of California San Francisco, CA, USA

Trial

Phase 3, TROPiCS-02

Conference

ASCO 2022

5 August, 2022 12:11

Shaky OS results of palbociclib in ER-positive/HER2-negative breast cancer 

Presented By

Prof. Richard Finn, David Geffen School of Medicine at UCLA, CA, USA

Trial

Phase 3, PALOMA-2

Conference

ASCO 2022

5 August, 2022 12:09

Practice-changing results of T-DXd in HER2-low breast cancer 

Presented By

Prof. Shanu Modi, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 3, DESTINY-Breast04

Conference

ASCO 2022

5 August, 2022 12:04

SET2,3 to inform on chemotherapy decisions in ER-positive breast cancer

Presented By

Dr Otto Metzger, Dana-Farber Cancer Institute, MA, USA

Trial

Phase 3, CALGB9741

Conference

ASCO 2022

5 August, 2022 11:59

Metastasis-directed therapy fails in oligometastatic breast cancer

Presented By

Dr Steven Chmura, University of Chicago, IL, USA

Trial

Phase 2, NRG-BR002

Conference

ASCO 2022

5 August, 2022 11:34

Analysis by residual cancer burden further clarifies effect of pembrolizumab

Presented By

Prof. Lajos Pusztai, Yale School of Medicine, CT, USA

Trial

Phase 3, KEYNOTE-522

Conference

ASCO 2022

5 August, 2022 11:26

Contribution of metastatic therapies on mortality reduction in breast cancer

Presented By

Prof. Jennifer Caswell-Jin, Stanford University, CA, USA

Conference

ASCO 2022

5 August, 2022 11:19

Radiotherapy may be omitted in breast cancer patients 

Presented By

Prof. Timothy Whelan, McMaster University, Canada

Trial

LUMINA

Conference

ASCO 2022

5 August, 2022 10:59

Promising data for ribociclib after progression on ET plus CDK4/6 inhibitors in HR-positive/HER2-negative metastatic breast cancer

Presented By

Prof. Kevin Kalinsky, Winship Cancer Institute of Emory University, GA, USA

Trial

Phase 2, MAINTAIN

Conference

ASCO 2022

5 August, 2022 10:53

7-gene biosignature: Benefits of endocrine therapy and radiotherapy in breast cancer risk groups

Presented By

Dr Pat Whitworth, Nashville Breast Cancer Center, TN, USA

Conference

ASCO 2022

5 August, 2022 10:44

ASCO 2022 Highlights Podcast

Presented By

Dr Robert van den Heuvel, Medicom

Conference

ASCO 2022

21 June, 2022 09:38

Diagnostic mammogram accuracy varies across racial/ethnic groups

Journal

Cancer Epidemiology, Biomarkers & Prevention

20 June, 2022 15:39

Which women benefit most from digital breast tomosynthesis?

Journal

JAMA

14 June, 2022 18:03

Radiation skin toxicity in women with larger breasts is reduced with prone positioning

Journal

JAMA Oncology

13 June, 2022 14:02

Promising reversal in early-stage breast cancer surgical choices

Journal

JAMA Surgery

9 June, 2022 18:16

Cancer research advances presented at ASCO 2022 -part 2

Conference

ASCO 2022

6 June, 2022 19:35

Gilead drug modestly delays breast cancer progression in late-stage trial

Conference

ASCO 2022

6 June, 2022 16:10

New data sets stage for broader use of AstraZeneca breast cancer drug

Conference

ASCO 2022

6 June, 2022 16:00

Low vitamin D tied to breast cancer risk in Hispanic women

Journal

Cancer

25 April, 2022 16:08

Should tomosynthesis replace mammography?

Journal

The Lancet Oncology

20 April, 2022 15:40

Lumpectomy on par with mastectomy for some young women

Conference

American Society of Breast Surgeons annual meeting

13 April, 2022 16:05

Positive lymph nodes not a reliable indicator for chemo in some women with breast cancer

Conference

American Society of Breast Surgeons annual meeting

12 April, 2022 18:14

Trastuzumab deruxtecan slashes disease progression, death by 72% in HER-2+ breast cancer

Journal

The New England Journal of Medicine

23 March, 2022 23:00

Mammograms may provide clues to heart-disease risk in older women

Journal

Circulation: Cardiovascular Imaging

15 March, 2022 19:33

Breast, cervical screening suboptimal in transgender individuals

Journal

American Journal of Clinical Oncology

10 March, 2022 23:32

Trispecific antibody activates CD 4 cells to curb breast cancer growth in mice

Journal

Nature

10 March, 2022 01:16

Adding ribociclib to letrozole boosts survival in some with advanced breast cancer

Journal

The New England Journal of Medicine

9 March, 2022 23:00

One in seven breast cancers “overdiagnosed” in women 50-74

Journal

Annals of Internal Medicine

28 February, 2022 23:23

Breast cancer therapy-related cardiac dysfunction likely diagnosed more accurately with combined testing

Journal

JAMA Cardiology

17 February, 2022 22:49

Early MRI breast-cancer screening could benefit women with non-BRCA mutations

Journal

JAMA Oncology

17 February, 2022 17:49

SABCS 2021 Focus in Genomic Profiling

Presented By

Dr Rachel Giles, Medicom

Conference

SABCS 2021

17 February, 2022 11:10

Use of sentinel-lymph-node biopsies rising in patients with inflammatory breast cancer, against guidelines

Journal

JAMA Network Open

15 February, 2022 17:50

DNA damage repair may be key to higher breast cancer mortality in Black women

Journal

Therapeutic Advances in Medical Oncology

14 February, 2022 23:23

Pyrotinib plus capecitabine promising for HER2-positive breast cancer brain metastases

Journal

The Lancet Oncology

11 February, 2022 22:43

Use of trastuzumab deruxtecan in breast cancer trials likely guided by inaccurate assays

Journal

JAMA Oncology

9 February, 2022 23:31

Pembrolizumab logs 37% improvement in event-free survival in triple-negative breast cancer

Journal

The New England Journal of Medicine

9 February, 2022 23:00

CECR2 protein pinpointed as driver of breast cancer metastases

Journal

Science Translational Medicine

8 February, 2022 22:20

Breast cancer subtypes vary by gene, affecting risk prediction, screening strategies

Journal

JAMA Oncology

2 February, 2022 23:03

Olaparib is well tolerated as an additional treatment

Presented By

Dr Patricia Ganz, UCLA School of Medicine, CA, USA

Trial

Phase 3, OlympiA

Conference

SABCS 2021

31 January, 2022 22:26

Race effects the likelihood to develop lymphoedema following breast cancer treatment

Presented By

Dr Andrea Barrio, Memorial Sloan-Kettering Cancer Center, NY, USA

Trial

Phase 2, I-SPY

Conference

SABCS 2021

31 January, 2022 22:25

Sentinel lymph node staging is non-inferior to complete axillary lymph node dissection

Presented By

Dr Damiano Gentile, Humanitas Research Hospital, Italy

Trial

SINODAR ONE

Conference

SABCS 2021

31 January, 2022 22:23

One in 7 breast cancers detected during screening are overdiagnosed

Presented By

Dr Marc Ryers , Duke University Medical Center, NC, USA

Conference

SABCS 2021

31 January, 2022 22:21

Using genomics to match treatments improves outcomes

Presented By

Prof. Fabrice André, Institut Gustave Roussy, France

Trial

Phase 2, SAFIR02-BREAST; SAFIR-PI3K

Conference

SABCS 2021

31 January, 2022 22:19

How tamoxifen can induce uterine cancer

Presented By

Dr Kirsten Kübler, Broad Institute, MA, USA

Conference

SABCS 2021

31 January, 2022 22:15

Loss of ASXL1 tumour suppressor promotes resistance to CDK4/6 inhibitors

Presented By

Dr Dhivya Sudhan, UT Southwestern Medical Center, TX, USA

Conference

SABCS 2021

31 January, 2022 22:12

Inducers of ferroptosis are potential drugs to target p53-mutated TNBC cells

Presented By

Dr William Tahaney, MD Anderson Cancer Center, TX, USA

Conference

SABCS 2021

31 January, 2022 22:10

MAPK-pathway alterations are associated with resistance to anti-HER2 therapy

Presented By

Dr Emanuela Ferraro, Memorial Sloan-Kettering Cancer Center, NY, USA

Conference

SABCS 2021

31 January, 2022 22:08

Genomic signatures of DCIS define biology and correlate with clinical outcomes

Presented By

Dr Siri Strand, Stanford University, CA, USA

Trial

TBCRC 038;RAHBT

Conference

SABCS 2021

31 January, 2022 18:11

BRCA2 linked to inferior outcomes with CDK4/6 inhibitors plus endocrine therapy

Presented By

Dr Anton Safonov, Memorial Sloan-Kettering Cancer Center, NY, USA

Conference

SABCS 2021

31 January, 2022 18:08

Datopotamab deruxtecan shows promising anti-tumour activity

Presented By

Dr Ian Krop, Dana-Farber Cancer Institute, MA, USA

Trial

Phase 1, TROPION-PanTumor01

Conference

SABCS 2021

31 January, 2022 18:05

Trastuzumab deruxtecan outperforms trastuzumab emtansine

Presented By

Dr Sara Hurvitz, University of California, CA, USA

Trial

Phase 3, DESTINY-Breast03

Conference

SABCS 2021

31 January, 2022 18:02

Nivolumab plus ipilimumab serve promising dual checkpoint inhibition

Presented By

Dr Romualdo Barroso-Sousa , Hospital Sírio-Libanês, Brazil

Trial

Phase 2, NIMBUS

Conference

SABCS 2021

31 January, 2022 17:59

Entinostat plus exemestane improves progression-free survival in Chinese patients

Presented By

Prof. Binghe Xu, Chinese Academy of Medical Sciences, China

Conference

SABCS 2021

31 January, 2022 17:57

Efficacy of pyrotinib plus capecitabine confirmed in previously treated patients

Presented By

Prof. Binghe Xu, Chinese Academy of Medical Sciences, China

Trial

Phase 3, PHOEBE

Conference

SABCS 2021

31 January, 2022 17:54

Single-cell spatial analysis can predict response to neoadjuvant immunotherapy

Presented By

Dr Giampaolo Bianchini, Ospedale San Raffaele, Italy

Trial

Phase 3, NeoTRIPaPDL1

Conference

SABCS 2021

31 January, 2022 17:48

Neoadjuvant pembrolizumab plus chemotherapy benefits event-free survival in TNBC

Presented By

Prof. Peter Schmid, Barts Cancer Institute, UK

Trial

Phase 3, KEYNOTE-522

Conference

SABCS 2021

31 January, 2022 17:45

Early use of ctDNA testing can identify likelihood of relapse in TNBC

Presented By

Prof. Nicholas Turner, The Institute of Cancer Research, UK

Trial

Phase 2, c-TRAK-TN

Conference

SABCS 2021

31 January, 2022 17:42

Pembrolizumab plus chemotherapy benefits patients with combined positive score ≥10

Presented By

Dr Javier Cortés, Vall d'Hebron Institute of Oncology, Spain

Trial

Phase 3, KEYNOTE-355

Conference

SABCS 2021

31 January, 2022 17:40

Neratinib plus trastuzumab plus fulvestrant shows encouraging clinical activity

Presented By

Dr Komal Jhaveri, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 2, SUMMIT

Conference

SABCS 2021

31 January, 2022 17:37

Addition of palbociclib to standard endocrine therapy does not improve outcome in adjuvant treatment

Presented By

Prof. Michael Gnant, Medical University of Vienna, Austria

Trial

Phase 3, PALLAS

Conference

SABCS 2021

31 January, 2022 17:31

The SERD elacestrant improves outcomes for patients unresponsive to endocrine therapy

Presented By

Dr Aditya Bardia, Massachusetts General Hospital, MA, USA

Trial

Phase 3, EMERALD

Conference

SABCS 2021

31 January, 2022 17:29

Consistent overall survival benefit of ribociclib in advanced breast cancer

Presented By

Prof. Lisa Carey & Dr Joyce O’Shaughnessy

Trial

Phase 3, MONALEESA

Conference

SABCS 2021

31 January, 2022 17:24

Premenopausal women benefit from adjuvant chemotherapy next to endocrine therapy

Presented By

Dr Kevin Kalinsky, Emory University Winship Cancer Institute, GA, USA

Trial

Phase 3, RxPONDER

Conference

SABCS 2021

31 January, 2022 17:19

Promising anti-tumour activity of the CDK7-inhibitor samuraciclib plus fulvestrant

Presented By

Prof. Charles Coombes, Imperial College London, UK

Conference

SABCS 2021

31 January, 2022 17:16

ctDNA is prognostic and predictive for response to ribociclib plus letrozole

Presented By

Dr Giampaolo Bianchini, San Raffaele Scientific Institute, Italy

Trial

Phase 3, BioItaLEE

Conference

SABCS 2021

31 January, 2022 17:13

Early switch to fulvestrant plus palbociclib beneficial for patients with ESR1 mutation

Presented By

Prof. François-Clément Bidard, Institut Curie, France

Trial

Phase 3, PADA-1

Conference

SABCS 2021

31 January, 2022 17:09

Aromatase inhibitors outperform tamoxifen in premenopausal women

Presented By

Ms Rosie Bradley, University of Oxford, UK

Trial

Phase 3, ABCGS12; TEXT; SOFT; HOBOE

Conference

SABCS 2021

31 January, 2022 16:49

Concurrent taxane plus anthracycline most beneficial in reducing risk of breast cancer

Presented By

Dr Jeremy Braybrooke, University Hospitals Bristol NHS Foundation Trust, UK

Conference

SABCS 2021

31 January, 2022 16:44

Reduced risk of recurrence with ovarian suppression plus tamoxifen/exemestane

Presented By

Dr Meredith Regan, Dana-Farber Cancer Institute, USA

Trial

Phase 3, TEXT; SOFT

Conference

SABCS 2021

31 January, 2022 16:36

Metformin does not improve outcomes in patients with early-stage breast cancer

Presented By

Dr Pamela Goodwin, Lunenfeld-Tanenbaum Research Institute, Canada

Trial

Phase 3, CCTGMA.32

Conference

SABCS 2021

31 January, 2022 16:32

Omitting sentinel lymph node biopsy improves arm symptoms

Presented By

Prof. Bernd Gerber, University of Rostock, Germany

Trial

INSEMA

Conference

SABCS 2021

31 January, 2022 16:29

Depression screening aids behavioral care referrals for breast cancer patients

Journal

JAMA

21 January, 2022 23:18

SABCS 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

SABCS 2021

10 January, 2022 20:59

Better breast-cancer outcomes seen with integrative care

Journal

Journal of Oncology

3 January, 2022 16:12

GnRHa therapy protects the ovaries of young women with breast cancer having chemo

Journal

JAMA Oncology

3 January, 2022 15:53

NOS inhibitor plus taxane promising for resistant triple negative breast cancer

Journal

Science Translational Medicine

21 December, 2021 23:30

Pyrotinib plus chemo may improve outcomes in pretreated HER2-positive breast cancer

Conference

San Antonio Breast Cancer Symposium

17 December, 2021 19:55

Tumor biology more important than race in predicting treatment response in breast cancer

Conference

San Antonio Breast Cancer Symposium (SABCS)

15 December, 2021 16:18

Breast-cancer patients with estrogen-receptor mutation may benefit from early treatment change

Conference

San Antonio Breast Cancer Symposium

13 December, 2021 17:03

Mammographic density linked to contralateral, but not ipsilateral, breast cancer risk in young survivors

Journal

JAMA Surgery

10 December, 2021 22:35

Matching breast-cancer treatments to high-value genomic alterations leads to better outcomes

Conference

San Antonio Breast Cancer Symposium

10 December, 2021 16:04

Elacestrant could become new standard of care for some breast-cancer patients

Conference

San Antonio Breast Cancer Symposium (SABCS)

9 December, 2021 16:06

Long-term safety of GnRHa affirmed in premenopausal women undergoing chemo for breast cancer

Journal

Journal of the National Cancer Institute

7 December, 2021 23:33

Fat cell alterations implicated in breast cancer metastases

Journal

Science Signaling

3 December, 2021 22:44

Structured exercise aids arm function after breast cancer surgery

Journal

The BMJ

1 December, 2021 23:07

Four in 10 fractures in breast cancer patients are pathologic

Journal

JAMA Network Open

26 November, 2021 21:23

Trastuzumab deruxtecan triples PFS

Presented By

Dr Javier Cortés, International Breast Cancer Center Barcelona, Spain

Trial

Phase 3, DESTINY-Breast03

Conference

ESMO 2021

19 November, 2021 09:51

Novel conjugate meets primary endpoint

Presented By

Dr Cristina Saura, Vall d’Hebron Institute of Oncology, Spain

Trial

Phase 3, TULIP

Conference

ESMO 2021

19 November, 2021 09:50

Longest survival benefit from first-line CDK4/6 inhibitor

Presented By

Prof. Gabriel Hortobagyi, University of Texas MD Anderson Cancer Center, USA

Trial

Phase 3, MONALEESA-2

Conference

ESMO 2021

19 November, 2021 09:50

Meta-analysis shows 6-months adjuvant trastuzumab is optimal

Presented By

Prof. Helena Earl, Addenbrooke's Hospital, UK

Conference

ESMO 2021

19 November, 2021 09:50

BrighTNess data may change guidelines

Presented By

Prof. Sibylle Loibl, German Breast Group, Germany

Trial

Phase 3, BrighTNess

Conference

ESMO 2021

19 November, 2021 09:49

Double-positive results for triple-negative metastatic breast cancer

Presented By

Prof. Hope Rugo, University of California, San Francisco, USA

Trial

Phase 3, KEYNOTE-355

Conference

ESMO 2021

19 November, 2021 09:48

Survival after neoadjuvant therapy with trastuzumab-lapatinib plus chemotherapy

Presented By

Prof. Valentina Guarneri, University of Padua, Italy

Conference

ESMO 2021

19 November, 2021 09:48

Postmenopausal breast cancer: extended letrozole reduces recurrence

Presented By

Prof. Lucia Del Mastro, University of Genoa, Italy

Trial

Phase 3

Conference

ESMO 2021

19 November, 2021 09:47

Asian women also benefit from palbociclib plus letrozole

Presented By

Prof. Binghe Xu, Peking Union Medical College, Beijing, China

Trial

Phase 3, PALOMA-4

Conference

ESMO 2021

19 November, 2021 09:47

No PEARLs of survival with palbociclib plus endocrine therapy compared with capecitabine, but QoL better

Presented By

Prof. Miguel Martín Jiménez, Complutense University of Madrid, Spain

Trial

Phase 3, PEARL

Conference

ESMO 2021

19 November, 2021 09:45

Women with breast cancer at increased risk for developing atrial fibrillation

Journal

European Heart Journal

18 November, 2021 16:25

Patients with advanced breast cancer denied opportunities to join clinical trials

Conference

Advanced Breast Cancer Sixth International Consensus Conference (ABC 6)

10 November, 2021 18:41

Acellular dermal matrix not tied to fewer reoperations after breast reconstruction

Journal

JAMA Network Open

4 November, 2021 22:09

Signs of heart disease may be more subtle in women than in men

Expert

Prof. Corrine Jurgens, Connell School of Nursing at Boston College, MA, USA

Journal

Circulation

26 August, 2022 02:32

New VOYAGER PAD data: Should patients with both PAD and CKD get rivaroxaban?

Presented By

Dr Mark Svet, University of Colorado, USA

Trial

VOYAGER-PAD

Conference

ACC 2022

15 June, 2022 15:24

COMPLETE revascularisation improves angina-related QoL

Presented By

Prof. Shamir Mehta, McMaster University, Canada

Trial

COMPLETE

Conference

ACC 2022

15 June, 2022 14:24

Plot twist for negative FAME 3 results: early QoL benefits of PCI

Presented By

Dr Frederik Zimmermann, Catharina Hospital, the Netherlands

Trial

FAME 3

Conference

ACC 2022

15 June, 2022 14:19

Chocolate Touch vs Lutonix catheters

Presented By

Prof. Mehdi Shishehbor, Harrington Heart & Vascular Institute, USA

Trial

Chocolate Touch

Conference

ACC 2021

15 June, 2022 13:53

No FLAVOUR difference between FFR and IVUS for PCI guidance

Presented By

Prof. Bon-Kwon Koo, Seoul National University College of Medicine, Korea

Trial

FLAVOUR

Conference

ACC 2022

15 June, 2022 13:49

Lipoprotein(a) slashed by 98% in APOLLO trial

Presented By

Prof. Steven Nissen, Cleveland Clinic, USA

Trial

Phase 1, APOLLO

Conference

ACC 2022

15 June, 2022 13:16

Adding PCSK9 inhibitor to rosuvastatin after acute MI improves coronary plaque reduction

Journal

08/06/2022

8 June, 2022 18:05

Is very high HDL cholesterol risky in heart patients?

Journal

JAMA Cardiology

20 May, 2022 15:59

Distal radial access does not impair hand function

Journal

JACC: Cardiovascular Intervention

17 May, 2022 15:50

FDA approves Bristol Myers’ oral heart disease drug

29 April, 2022 15:23

ACS patients with several metabolic risk factors may benefit most from PCSK9 inhibitors

Journal

The Lancet Diabetes & Endocrinology

20 April, 2022 15:43

ACC 2022 Highlights Podcast

Presented By

Dr Rachel Giles

Journal

Medicom

Conference

ACC 2022

20 April, 2022 10:50

Co-prescribed PDE5 inhibitors and nitrates not tied to adverse outcomes

Journal

Annals of Internal Medicine

18 April, 2022 23:00

Potential genetic culprit for spontaneous coronary-artery dissection

Journal

JAMA Cardiology

24 March, 2022 21:53

Serious mental illness tied to increased CV risk, starting in young adulthood

Journal

Journal of the American Heart Association

16 March, 2022 20:11

CT as effective as invasive angiography for guiding treatment of stable chest pain

Journal

The New England Journal of Medicine

4 March, 2022 15:41

Conflicting periprocedural MI definitions impact clinical practice, research

Journal

Journal of the American College of Cardiology

7 February, 2022 22:35

Pilot trial shows potential benefit of stem-cell therapy in microvascular dysfunction

Journal

Circulation: Cardiovascular Interventions

2 February, 2022 16:15

Apixaban plus P2Y12 inhibitor likely best for AF after ACS or PCI

Journal

Journal of the American College of Cardiology

31 January, 2022 23:26

Whether treated with CABG or PCI, heavily calcified lesions tied to higher mortality

Journal

JACC: Cardiovascular Interventions

25 January, 2022 16:41

Early surgery outperforms conservative management in asymptomatic severe aortic stenosis

Presented By

Prof. Marko Banovic, University Clinical Centre of Serbia, Serbia

Trial

AVATAR

Conference

AHA 2021

14 January, 2022 16:11

External support device for SVG grafts in CABG surgery shows promise

Presented By

Prof. John Puskas, Mount Sinai Hospital, Israel

Trial

VEST Pivotal

Conference

AHA 2021

14 January, 2022 16:04

Cardiac telerehabilitation is cost-effective for coronary artery disease

Journal

JAMA Network Open

6 January, 2022 21:38

Carefully selected patients can go home the day after PCI for STEMI

Journal

Journal of the American College of Cardiology

13 December, 2021 23:38

Extracoronary vascular events likely rare after spontaneous coronary artery dissection

Journal

JAMA Cardiology,

2 December, 2021 11:30

AHA 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

AHA 2021

30 November, 2021 23:20

Time from stopping blood thinner to CABG can be safely shortened

Journal

American Heart Association Scientific Sessions 2021

16 November, 2021 15:58

Bypass still better than stenting in severe heart disease – study

Journal

The New England Journal of Medicine

4 November, 2021 16:41

Coronary calcium score alone of limited value in younger patients with suspected CAD

Journal

JAMA Cardiology

2 November, 2021 19:12

Heart scans can help guide chronic total occlusion PCI

Journal

JACC: Cardiovascular Imaging

22 October, 2021 18:15

Polypills effective for primary prevention of cardiovascular disease

Journal

The Lancet

2 September, 2021 16:07

Same-day discharge after elective PCI safe, catching on

Journal

JACC: Cardiovascular Interventions

6 August, 2021 17:01

Adding rivaroxaban to aspirin may help some CAD, PAD patients live longer

Journal

Journal of the American College of Cardiology

13 July, 2021 21:50

Men and women benefit equally from early aspirin withdrawal following PCI

Presented By

Dr Birgit Vogel, Icahn School of Medicine, USA

Trial

TWILIGHT

Conference

ACC 2021

9 July, 2021 23:24

Prasugrel better than ticagrelor in ACS patients undergoing PCI

Journal

JAMA Cardiology

9 July, 2021 20:00

Better outcomes with invasive strategy if anatomic complete revascularisation is possible

Presented By

Dr Gregg Stone, Mount Sinai Medical Centre, USA

Trial

ISCHEMIA

Conference

ACC 2021

9 July, 2021 10:20

PCI for chronic total occlusion more successful after coronary CTA

Journal

JACC: Cardiovascular Imaging

5 July, 2021 18:00

Subgroup of patients with high heart rate response and coronary artery disease benefit from CPAP

Presented By

Prof. Ali Azarbarzin, Harvard Medical School, MA, USA

Trial

Phase 4, RICCADSA

Conference

ATS 2021

5 July, 2021 13:49

Lower burden of high-risk atherosclerotic plaques in psoriasis patients treated with biologics

Presented By

Prof. Nehal N. Mehta, National Heart, Lung, and Blood Institute, MD, USA

Conference

AAD VMX 2021

7 June, 2021 13:30

PCI for in-stent chronic total occlusion shows in-hospital success

Journal

JACC: Cardiovascular Interventions

3 June, 2021 16:17

Benefits of multivessel PCI unclear in patients with NSTEMI and cardiogenic shock

Journal

JACC: Cardiovascular Interventions

24 May, 2021 16:08

Bleeding, vascular complication rates lower when transradial PCI replaces transfemoral PCI

Journal

JACC: Cardiovascular Interventions

20 May, 2021 22:23

Memory decline in older adults similar with CABG and PCI

Journal

JAMA

18 May, 2021 23:08

Higher bleeding risk in women after PCI mostly due to baseline sex differences

Journal

JAMA Cardiology

17 May, 2021 16:42

No age cap for lipid-lowering therapy

Presented By

Prof. Børge Nordestgaard, University of Copenhagen, Denmark

Journal

Physician’s Weekly

Conference

AHA Scientific Sessions 2020

15 April, 2021 15:28

Cancer patients have higher readmission rates for heart attack, bleeding after PCI

Journal

European Heart Journal

11 March, 2021 16:28

Extra imaging reveals cause of MINOCA in women

Presented By

Prof. Harmony Reynolds, New York University Grossman School of Medicine, USA

Trial

HARP-MINOCA

Conference

AHA 2020

18 February, 2021 10:50

Ticagrelor not superior to clopidogrel after elective PCI

Presented By

Prof. Johanne Silvain, Sorbonne University, France

Trial

Phase 3, ALPHEUS

Conference

AHA 2020

18 February, 2021 10:43

Long-term mortality after coronary-artery occlusion may not depend on recanalization status

Journal

The Journal of the American College of Cardiology

15 February, 2021 20:46

Benzodiazepines given for ACS anxiety, pain may trigger posttraumatic stress symptoms

Journal

Journal of the American Heart Association

21 January, 2021 23:13

Calcium chloride during CABG curbs subsequent atrial fibrillation

Journal

Journal of the American College of Cardiology

18 January, 2021 19:08

Model to predict bleeding, thrombotic risks may help tailor PCI management

Journal

JAMA Cardiology

15 January, 2021 15:59

DASH-diet intervention might slow progression of nonobstructive coronary atherosclerosis

Journal

JACC: Cardiovascular Imaging

8 January, 2021 16:19

Higher levels of diet-derived antioxidants don’t protect against heart disease

Journal

Journal of the American College of Cardiology

4 January, 2021 20:11

CABG grafting risk thresholds differ between men and women

Journal

JAMA Cardiology

29 December, 2020 18:53

Study supports routine physiologic assessment to guide revascularization

Journal

JAMA

16 November, 2020 23:06

Trimetazidine after successful PCI not associated with fewer cardiac events

Presented By

Prof. Roberto Ferrari, University of Ferrara, Italy

Trial

ATPCI trial

Conference

ESC 2020

5 November, 2020 13:30

Low-dose colchicine reduces CV death and ischaemic events in coronary disease

Presented By

Dr Stefan Nidorf, Heart Care Western Australia, Australia

Trial

LoDoCo2 trial

Conference

ESC 2020

5 November, 2020 13:19

Rivaroxaban protects limbs and ischaemic events in CAD-PAD patients

Presented By

Prof. William Hiatt, University of Colorado, USA

Trial

VOYAGER PAD trial

Conference

ESC 2020

5 November, 2020 12:57

Reduced progression of coronary atherosclerosis with icosapent ethyl

Presented By

Prof. Matthew Budoff, Harbor-UCLA Medical Center, USA

Trial

EVAPORATE trial

Conference

ESC 2020

5 November, 2020 12:48

No difference in net adverse clinical events with clopidogrel, ticagrelor after PCI

Journal

JAMA

27 October, 2020 18:28

Mortality lower after coronary bypass surgery than after percutaneous interventions

Journal

JAMA Internal Medicine

21 October, 2020 17:07

Intravascular lithotripsy safely treats severely calcified coronary-artery disease

Journal

Journal of the American College of Cardiology

21 October, 2020 16:43

Fewer adverse events with ticagrelor monotherapy after 3 months DAPT

Presented By

Prof. Y.S. Jang, Yonsei University, South Korea

Trial

TICO

Conference

ACC 2020

8 September, 2020 15:29

TWILIGHT sub-study: same outcomes for diabetes patients

Presented By

Prof. D. Angiolillo, University of Florida - Jacksonville, USA

Trial

TWILIGHT, TWILIGHT-DM

Conference

ACC 2020

8 September, 2020 15:24

TWILIGHT sub-study: complex PCI patients

Presented By

Prof. G. Dangas, Icahn School of Medicine at Mount Sinai, USA

Trial

TWILIGHT

Conference

ACC 2020

8 September, 2020 15:20

Apixaban in AF patients with recent ACS/PCI: Drop aspirin after 30 days

Presented By

Prof. J. Alexander, Duke University, USA

Trial

AUGUSTUS

Conference

ACC 2020

8 September, 2020 14:06

Radial artery best for second bypass

Presented By

Prof. M. Gaudino, Weill Cornell Medicine, USA

Trial

RADIAL

Conference

ACC 2020

8 September, 2020 12:50

PCI and CABG are equal in left main CAD

Presented By

Dr D.W. Park, Asan Medical School, South Korea

Trial

PRECOMBAT

Conference

ACC 2020

8 September, 2020 12:45

TAILOR-PCI misses endpoint but still provides valuable insights

Presented By

Prof. N. Pereira, Mayo Clinic, USA

Trial

TAILOR-PCI

Conference

ACC 2020

7 September, 2020 23:16

Drop aspirin after 3 months in non-STEMI ACS patients on dual antiplatelet therapy

Presented By

Prof. Usman Baber, Icahn School of Medicine at Mount Sinai, USA

Trial

TWILIGHT

Conference

AHA 2019

26 February, 2020 20:58

Immediate coronary angiography after cardiac arrest does not improve survival

Presented By

Dr Jorrit Lemkes, Amsterdam University Medical Center, the Netherlands

Trial

COACT

Conference

AHA 2019

26 February, 2020 19:00

Complete revascularisation for obstructive non-culprit lesions with vulnerable plaque

Presented By

Dr Natalia Pinilla-Echeverri, McMaster University, Canada

Trial

COMPLETE

Conference

AHA 2019

26 February, 2020 18:02

Colchicine: no difference in peri-procedural cardiovascular events 30 days post-PCI

Presented By

Dr Binita Shah, NYU School of Medicine, USA

Trial

COLCHINE-PCI

Conference

AHA 2019

26 February, 2020 17:04

Intra-aortic balloon pump better than Impella: new observational data

Presented By

Dr Sanket S. Dhruva, University of California, San Francisco, USA

Conference

AHA 2019

26 February, 2020 15:06

ISCHEMIA trial: Invasive treatment only better for angina burden

Presented By

Prof. Judith Hochman, New York University School of Medicine, USA

Trial

ISCHEMIA

Conference

AHA 2019

26 February, 2020 14:17

Patients with polyvascular disease significantly undertreated with lipid lowering therapies

Conference

ACC 2019

4 June, 2019 15:12

ERS 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

ERS 2022

22 September, 2022 02:57

COVID-19 elevates risk of neurodegenerative disorders

Presented By

Dr Pardis Zarifkar, Rigshospitalet, Denmark

Conference

EAN 2022

22 August, 2022 17:03

More headaches in adolescents during COVID-19 pandemic

Presented By

Dr Ayşe Nur Özdag Acarli, Ermenek State Hospital, Turkey

Conference

EAN 2022

22 August, 2022 16:59

AstraZeneca vaccination and risk of cerebral venous sinus thrombosis

Presented By

Dr Jonathan Coutinho, Amsterdam University Medical Centre, the Netherlands

Conference

EAN 2022

22 August, 2022 16:55

Large impact of COVID-19 on dementia diagnosis and care

Presented By

Prof. Bengt Winblad, Karolinska Institutet, Sweden

Conference

EAN 2022

22 August, 2022 16:49

Social distancing led to a reduced number of exacerbations in bronchiectasis patients

Conference

NLC 2022

17 August, 2022 15:42

The role of CPAP and HFNC in COVID-19

Conference

NLC 2022

17 August, 2022 15:12

SPRINTER: SNG001 still in the running?

Presented By

Dr Philip Monk , Synairgen Research LtD, UK

Trial

Phase 3, SPRINTER

Conference

ATS 2022

18 July, 2022 14:04

Nebulised aviptadil “futile” in I-SPY COVID-19 trial

Presented By

Prof. Carolyn Calfee, University of California at San Francisco, CA, USA

Trial

Phase 2, I-SPY COVID-19

Conference

ATS 2022

18 July, 2022 14:01

Lung transplantation after COVID-19-associated ARDS

Presented By

Prof. G.R. Scott Budinger, Northwestern University, IL, USA

Conference

ATS 2022

18 July, 2022 13:59

COVI-PRONE trial on its back

Presented By

Prof. Waleed Alhazzani, McMaster University, Canada

Trial

COVI-PRONE

Conference

ATS 2022

18 July, 2022 13:57

Mesenchymal stem cells offer no benefit in COVID-19

Presented By

Dr Ellen Gorman, Queen’s University Belfast, UK

Trial

Phase 2, REALIST-COVID

Conference

ATS 2022

18 July, 2022 13:55

Alpha-1 antitrypsin for ARDS secondary to severe COVID-19

Presented By

Dr Oliver McElvaney, Royal College of Surgeons, Ireland

Trial

Phase 2

Conference

ATS 2022

18 July, 2022 13:53

Frailty prevalent 5 months following hospitalisation for COVID-19

Presented By

Dr Hamish McAuley, University of Leicester, UK

Trial

PHOSP-COVID

Conference

ATS 2022

18 July, 2022 13:51

Paediatric long COVID lacks definitions

Presented By

Ms Nadia Baalbaki, Emma Children’s Hospital, the Netherlands

Conference

ATS 2022

18 July, 2022 13:49

EAN 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

EAN 2022

14 July, 2022 09:07

Longer time between COVID shots may protect young men from heart inflammation

Journal

JAMA Network Open

27 June, 2022 19:39

Use of statins for primary prevention tied to lower risk of hospitalization for COVID-19

Journal

Journal of the American Heart Association

24 June, 2022 16:18

Neurological symptoms of COVID-19 can last months

Journal

Annals of Clinical and Translational Neurology

17 June, 2022 23:51

COVID-19 increases the mortality rates of patients with ALD

Presented By

Dr Yee Hui Yeo, Cedars-Sinai Medical Center, CA, USA

Conference

DDW 2022

14 June, 2022 22:43

Cancer patients over-represented in long COVID group

Conference

ASCO 2022

7 June, 2022 19:29

Breakthrough COVID-19 in cancer patients is often serious

7 June, 2022 19:26

Blood cancer patients show strong T-cell response to COVID vaccines

Conference

ASCO 2022

7 June, 2022 19:23

Cognitive, EEG, and MRI features in COVID-19 survivors

Presented By

Dr Giordano Cecchetti, Vita-Salute San Raffaele University, Italy

Conference

AAN 2022

2 June, 2022 17:41

Neurological manifestations of COVID-19 worsen prognosis

Presented By

Dr Anna Cervantes-Arslanian, Boston University School of Medicine, MA, USA

Conference

AAN 2022

2 June, 2022 17:35

New evidence for biological basis of “COVID-19 brain fog”

Presented By

Dr Joanna Hellmuth, University of California, CA, USA

Conference

AAN 2022

2 June, 2022 17:26

Impact of COVID-19 public health interventions

Presented By

Mr Ari Vandersluis, Heritage College of Osteopathic Medicine, OH, USA

Conference

AAN 2022

2 June, 2022 17:07

Telemedicine during COVID-19 pandemic highly appreciated

Presented By

Dr Chia-Chun Chiang, Mayo Clinic, MN, USA

Conference

AAN 2022

2 June, 2022 14:38

COVID vaccination especially important for dialysis patients

Journal

Clinical Journal of the American Society of Nephrology

1 June, 2022 23:00

Vaccine protection wanes faster for cancer patients

Journal

The Lancet Oncology

26 May, 2022 23:16

‘Startling’ heart attack finding in COVID patients

Journal

Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI)

25 May, 2022 15:49

AD treatment during the pandemic: dupilumab does not raise COVID-19 infection risk

Presented By

Dr Brian Rankin, University of Calgary, Canada

Trial

Cohort study

Conference

AAD 2022

18 May, 2022 12:27

Old cancer diagnosis not linked with worse COVID-19 outcomes

Journal

PLOS One

9 May, 2022 23:14

Pfizer/BioNTech vaccine safe after myocarditis

Conference

ESC Acute CardioVascular Care 2022

18 April, 2022 23:32

Lessons from the COVID-19 pandemic for IBD management

Presented By

Prof. Siew Ng, Chinese University of Hong Kong, Hong Kong

Conference

ECCO 2022

12 April, 2022 17:32

Lung damage may persist long after COVID-19 pneumonia clears

Journal

Radiology

4 April, 2022 16:02

Impact of COVID-19 on screening for colorectal cancer

Presented By

Dr John Carethers, University of Michigan, MI, USA

Conference

ASCO GI 2022

21 March, 2022 10:23

COVID-19 vaccines effective in younger patients with childhood-onset rheumatic diseases

Journal

Rheumatology

17 March, 2022 16:16

ACC issues consensus document on cardiovascular consequences of COVID-19

Journal

Journal of the American College of Cardiology

16 March, 2022 21:58

COVID-19 can cause brain shrinkage, memory loss – study

Journal

 Nature

8 March, 2022 15:38

Cancer treatments do not impair COVID-19 survival

Journal

JAMA Network Open

4 March, 2022 23:28

Alzheimer’s-like changes seen in COVID-19 patients’ brains

Journal

Alzheimer's & Dementia; bioRxiv; Preprints with The Lancet

4 February, 2022 23:44

Support for fourth COVID-19 jab in blood-cancer patients

Journal

The Lancet

3 February, 2022 17:29

DLQI scores underestimated during lockdowns?

Presented By

Dr Ali Alsharqi, St. Vincent’s University Hospital, Ireland

Conference

PFGC 2021

3 February, 2022 10:34

TNF blockers likely beneficial for psoriatic patients with COVID-19

Presented By

Prof. Catherine Smith, King’s College London, UK

Trial

PsoProtect

Conference

PFG 2021

2 February, 2022 15:42

Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion

Presented By

Dr Ali Al-Janabi, University of Manchester, UK

Conference

PFGC 2021

2 February, 2022 15:22

COVID-19 vaccines seem safe, generally well tolerated in rheumatic, musculoskeletal diseases

Journal

Annals of the Rheumatic Diseases

24 January, 2022 23:08

Blood pressure control disrupted during the pandemic

Presented By

Dr Alanna Chamberlain, Mayo Clinic, USA

Conference

AHA 2021

14 January, 2022 16:43

Icosapent ethyl did not reduce the risk of hospitalisation in COVID-19

Presented By

Dr Rafael Díaz, Estudios Clínicos Latinoamérica, Argentina

Trial

PREPARE IT-2

Conference

AHA 2021

14 January, 2022 16:37

Neutral effect of P2Y12 inhibitors in non-critical COVID-19 hospitalisations

Presented By

Prof. Jeffrey Berger, New York University Langone, USA

Trial

ACTIV-4A

Conference

AHA 2021

14 January, 2022 16:30

COVID-19 mRNA vaccination benefits outweigh the risk for myocarditis

Presented By

Prof. Biykem Bozkurt, Baylor College of Medicine Houston, USA

Conference

AHA 2021

14 January, 2022 16:24

Vaccine booster improves immune response in patients treated with rituximab

Presented By

Prof. Michael Bonelli, Medical University of Vienna, Austria

Conference

ACR 2021

14 January, 2022 11:07

Vaccinated rheumatic patients carry increased risk for COVID-19 breakthrough infections

Presented By

Prof. Jasvinder Singh, University of Alabama at Birmingham, AL, USA

Conference

ACR 2021

14 January, 2022 10:47

B-cell depleting medication increases COVID-19 breakthrough infection outcome risk

Presented By

Prof. Jean Liew, Boston University, MA, USA

Conference

ACR 2021

14 January, 2022 10:45

COVID-19 mRNA vaccine safe and tolerable in adults with autoimmune disease

Presented By

Dr Inés Colmegna, McGill University Health Centre, Canada

Conference

ACR 2021

14 January, 2022 10:06

Lupus patients less protected by COVID-19 vaccine

Presented By

Dr Peter Izmirly, New York University Grossman School of Medicine, NY, USA

Conference

ACR 2021

14 January, 2022 10:00

Laboratory and clinical signs 24h after hospitalisation predict MIS-C in children

Presented By

Dr Matthew Clark, Vanderbilt University Medical Center, TN, USA

Conference

ACR 2021

14 January, 2022 09:55

Long COVID “brain fog” shares features with “chemo brain”

Journal

bioRxiv

12 January, 2022 23:57

Long COVID “brain fog” shares features with “chemo brain”

Journal

bioRxiv

12 January, 2022 23:57

Breakthrough COVID-19 often severe in cancer patients

Journal

Annals of Oncology

27 December, 2021 23:16

Rivaroxaban cuts blood clot risk after COVID-19 hospital discharge

Journal

Lancet

22 December, 2021 17:05

MS patients at risk of hampered immune response after vaccination

Presented By

Prof. Maria Pia Sormani, University of Genoa, Italy

Conference

ECTRIMS 2021

9 December, 2021 10:49

Immunotherapy in MS does not influence COVID-19 severity and mortality

Presented By

Dr Gabriel Bsteh, Medical University of Vienna, Austria

Conference

ECTRIMS 2021

9 December, 2021 10:45

Anti-CD20 antibodies associated with worse COVID-19 outcomes

Presented By

Dr Steve Simpson-Yap, University of Melbourne, Australia

Conference

ECTRIMS 2021

9 December, 2021 10:41

ECTRIMS-EAN consensus on vaccination in MS patients

Presented By

Dr Mauricio Farez, Fundacion FLENI, Argentina

Conference

ECTRIMS 2021

9 December, 2021 10:35

Cancer patients benefit from mRNA vaccines

Journal

JAMA Oncology

6 December, 2021 21:47

Apixaban tops rivaroxaban for repeat-VTE protection in real-world analysis

Journal

Annals of Internal Medicine

6 December, 2021 11:34

Rituximab likely raises risk of hospital death in COVID-19 patients

Journal

The Lancet Rheumatology

1 December, 2021 22:32

Study reveals spectrum of COVID-19 brain complications

Conference

Radiological Society of North America annual meeting

30 November, 2021 20:15

Cardiopulmonary exercise test helps define the cause of unexplained dyspnea in COVID long-haulers

Journal

JACC: Heart Failure

29 November, 2021 21:16

Connecting, challenging, and empowering youth through their smartphone

Presented By

Prof. Manon Hillegers , Erasmus MC Sophia, the Netherlands

Conference

ECNP 2021

26 November, 2021 11:36

Alcohol consumption during lockdown

Presented By

Ms Agnese Merlo & Ms Pauline A. Hendriksen, Utrecht Institute for Pharmaceutical Sciences

Conference

ECNP 2021

26 November, 2021 11:19

Post-COVID-19 depression responds well to SSRIs

Presented By

Dr Mario Mazza , San Raffaele University, Italy

Conference

ECNP 2021

26 November, 2021 11:17

Impact of COVID-19 on patients with psychotic disorders

Presented By

Dr Amir Krivoy, Tel-Aviv University, Israel

Conference

ECNP 2021

26 November, 2021 11:14

‘Glimpse of hope’ when anti-CD20 drugs limit vaccine antibodies

Journal

Clinical Infectious Diseases,

25 November, 2021 19:19

COVID-19 survival has improved for European cancer patients

Journal

JAMA Oncology

25 November, 2021 19:16

Dupilumab for atopic dermatitis linked with milder COVID-19 symptoms

Journal

The Journal of Allergy and Clinical Immunology: In Practice

25 November, 2021 16:58

Support for COVID-19 booster shots in cancer patients

Journal

Cancer Cell

23 November, 2021 18:20

Adequate response to SARS-CoV-2 vaccine in cancer patients

Presented By

Dr Sjoukje Oosting, University Medical Center Groningen, the Netherlands & Dr Scott Shepherd, Royal Marsden NHS Foundation Trust, UK

Trial

VOICE & CAPTURE

Conference

ESMO 2021

19 November, 2021 09:15

Cancer patients more likely to die from COVID-19 when hospital admittance is required

Presented By

Dr Tom Drake, University of Edinburgh, UK

Conference

ESMO 2021

19 November, 2021 09:15

Third global survey of the ESMO Resilience Task Force

Presented By

Dr Jonathan Lim, Imperial College London, UK

Conference

ESMO 2021

19 November, 2021 09:15

High COVID-19 mortality in Swiss cancer patients

Presented By

Dr Markus Joerger, Cantonal Hospital St Gallen, Switzerland

Conference

ESMO 2021

19 November, 2021 09:14

Damaged skin as a possible transmission route for SARS-CoV-2

Presented By

Dr Hanan Osman-Ponchet

Conference

EADV 2021

18 November, 2021 13:24

Lung cancer patients respond well to COVID-19 vaccines

Journal

Journal of Thoracic Oncology

15 November, 2021 23:00

Anti-TNF therapy tied to better outcomes in IBD patients with COVID-19

Journal

Inflammatory Bowel Diseases

12 November, 2021 21:45

COVID-19 tied to a wide range of ECG findings

Journal

Cardiac Electrophysiology Clinics

10 November, 2021 22:59

Higher inflammation markers in COVID-19 patients with a first negative PCR test

Presented By

Dr Thomas Gille, Université Paris 13, France

Conference

ERS 2021

9 November, 2021 10:31

Breathing techniques contributed to COVID-19 recovery

Conference

ERS 2021

9 November, 2021 10:30

Persistent fatigue following COVID-19

Presented By

Ms Zjala Ebadi, Radboud University Medical Center, the Netherlands

Conference

ERS 2021

9 November, 2021 10:30

Risk of COVID-19-related morbidity and mortality in young and middle-aged adults

Presented By

Dr Eva Tabernero Huguet, Hospital Universitario Cruces, Spain

Conference

ERS 2021

9 November, 2021 10:30

Fear of COVID-19 related to dyspnoea in COPD patients

Conference

ERS 2021

9 November, 2021 10:29

Impact of COVID-19 on the dynamics of respiratory viruses

Conference

ERS 2021

9 November, 2021 10:29

The effect of the pandemic on the discharge diagnosis of older COPD patients

Conference

ERS 2021

9 November, 2021 10:25

Dynamics of environmental pollution during and after COVID-19 lockdown

Trial

POLCOV

Conference

ERS 2021

9 November, 2021 10:20

Telemedicine beneficial for headache care during the pandemic

Presented By

Dr Chia-Chun Chiang , Mayo Clinic, NY, USA

Conference

IHC 2021

8 November, 2021 13:58

Comparison of headaches after SARS-CoV-2 vaccination

Presented By

Dr Carl Göbel, Universitätsklinikum Schleswig-Holstein, Germany

Conference

IHC 2021

8 November, 2021 13:55

Grey matter cortical changes in patients with persistent headache after COVID-19

Presented By

Dr Álvaro Planchuelo-Gómez, Universidad de Valladolid, Spain

Conference

IHC 2021

8 November, 2021 13:43

Increased risk of cerebral venous thrombosis in COVID-19

Presented By

Dr Sajid Hameed , Aga Khan University, Pakistan

Conference

IHC 2021

8 November, 2021 13:26

Two-dose COVID-19 vaccination may not lead to flares in RA patients

Journal

Annals of the Rheumatic Diseases

3 November, 2021 16:50

More adults embraced at-home colorectal-cancer screening during pandemic

Conference

American College of Surgeons (ACS) Clinical Congress 2021

29 October, 2021 15:39